Actinium Pharmaceuticals
ATNM
#10095
Rank
โ‚ฌ31.51 M
Marketcap
1,00ย โ‚ฌ
Share price
-6.40%
Change (1 day)
-36.96%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -โ‚ฌ33.81 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.09 Million. In 2024 the company made an earning of -โ‚ฌ36.17 Million, an increase over its 2023 earnings that were of -โ‚ฌ44.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ33.81 Million-6.51%
2024 -โ‚ฌ36.17 Million-18.87%
2023 -โ‚ฌ44.58 Million52.24%
2022 -โ‚ฌ29.28 Million36.61%
2021 -โ‚ฌ21.44 Million11.48%
2020 -โ‚ฌ19.23 Million1.46%
2019 -โ‚ฌ18.95 Million-7.37%
2018 -โ‚ฌ20.46 Million-11.46%
2017 -โ‚ฌ23.11 Million10.67%
2016 -โ‚ฌ20.88 Million15.7%
2015 -โ‚ฌ18.05 Million-14.86%
2014 -โ‚ฌ21.2 Million129.19%
2013 -โ‚ฌ9.25 Million-8.55%
2012 -โ‚ฌ10.12 Million
2010 โ‚ฌ0 M-152.15%
2009 -โ‚ฌ0.02 Million-39.8%
2008 -โ‚ฌ0.03 Million120.29%
2007 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-โ‚ฌ31.93 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.16 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B-1,132.71%๐Ÿ‡บ๐Ÿ‡ธ USA